Jiankai Technology: Announcement on the progress of share repurchases through centralized bidding transactions
Announcement on the progress of the repurchase of shares through centralized bidding transactions
Jiankai Technology: Announcement on Voluntary Disclosure of Polyethylene Glycol Irinotecan for the Treatment of Small Cell Lung Cancer Phase III Clinical Trials Completing the Enrollment of the First Case
Notice on Voluntary Disclosure of Polyethylene Glycol Irinotecan for the Treatment of Small Cell Lung Cancer Phase III Clinical Trials Completing the Enrollment of the First Case
Announcement on attending the 2024 Semi-Annual Science and Technology Innovation Board Special Group Results Briefing on Pharmaceuticals and Biological Products
Announcement on the Phase II Study on Voluntary Disclosure of the Safety, Tolerability and Initial Efficacy of Polyethylene Glycol Irinotecan as a Single Drug for Small Cell Lung Cancer
Investor Relations Activity Record Form 20240903
Announcement on the progress of the repurchase of shares through centralized bidding transactions
Opinions of the board of supervisors of Beijing Jiankai Technology Co., Ltd. on the verification of the ownership list for the second vesting period reserved for the company\'s 2021 restricted stock incentive plan
Announcement on the 2021 Restricted Stock Incentive Plan Reservation Grant Section Eligible for the Second Vesting Period
Semi-annual Evaluation Report on the 2024 Special Action Plan to Improve Quality, Increase Efficiency, and Value Returns
Announcement of Resolutions of the 9th Meeting of the Third Board of Directors
2024 Semi-Annual Report
Announcement of Resolutions of the Seventh Meeting of the Third Board of Supervisors
Announcement on abolishing part of the 2021 Restricted Stock Incentive Plan to grant restricted stocks that have not yet been vested
Announcement on the adjustment of the price granted under the 2021 Restricted Stock Incentive Plan
Verification opinion of CITIC Securities Co., Ltd. on the use of temporarily idle funds raised by Beijing Jiankai Technology Co., Ltd. for cash management
Notice on the use of idle raised funds for cash management
Legal opinion of Beijing Anjie Shizhe Law Firm on matters relating to the adjustment of the grant price of the 2021 restricted stock incentive plan of Beijing Jiankai Technology Co., Ltd., the second vesting period of the reserved grant period meets the conditions of ownership, and the cancellation of restricted shares granted that have not yet been vested
2024 Semi-Annual Report Summary
No Data
No Data